Screening Tags Alerts

Kailera Therapeutics, Inc.

KLRA·NASDAQ·$21.57Share Price as of 11/2·$3BMarket Cap as of 11/2

Financials

10-QQuarter ended 06/30/2608/12/26 10-QQuarter ended 03/31/2605/26/26

Disclosures

8-KCurrent report08/12/26 8-KCurrent report05/26/26 8-KCurrent report04/20/26

Prospectuses and Registrations

424B4Prospectus04/17/26 S-8Registration of securities for employees04/17/26 S-1MEFProspectus / registration04/16/26 S-1/ARegistration statement (amended)04/13/26 S-1Registration statement (IPO)03/27/26

Proxies

No matching filings.

Ownership

Form 3Initial insider ownership09/09/26 Form 4Insider transaction09/09/26 SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership08/05/26

Other

EFFECTRequest for effectiveness04/16/26 CERTCEO/CFO certification04/15/26 8-A12B8-A12B04/14/26 DRS/ADRS/A02/11/26 DRSDRS12/19/25

Latest Filings

10-QQuarter ended 06/30/2608/12/26 8-KCurrent report08/12/26 10-QQuarter ended 03/31/2605/26/26 8-KCurrent report05/26/26 8-KCurrent report04/20/26

Ownership

Form 3Initial insider ownership09/09/26 Form 4Insider transaction09/09/26 SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership08/05/26

Baxion © 2026
Terms
Privacy
Contact